TY - JOUR
T1 - Untangling the evolutionary roots of lung cancer
AU - Devarakonda, Siddhartha
AU - Govindan, Ramaswamy
N1 - Funding Information:
Competing interests: S.D. serves on the steering committee for Guardant 360 but does not accept financial compensation. R.G. has received honoraria for consulting from AbbVie, Genentech, Janssen, AstraZeneca, EMD Sereno, BMS, Pfizer, Nektar, Merck, Celgene, and GSK. RG’s work is supported in part by an NCI grant (U54CA224083 Washington University PDX Development and Trial Center). S.D. and R.G. are principal investigators on industry sponsored clinical trials for which their institution receives funding and research support.
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12/1
Y1 - 2019/12/1
N2 - The genomic and host factors that drive the progression of pre-invasive lesions in non-small cell lung cancer are poorly understood. Studying these factors can advance our knowledge of lung cancer biology, aid in the development of better screening strategies and improve patient outcomes.
AB - The genomic and host factors that drive the progression of pre-invasive lesions in non-small cell lung cancer are poorly understood. Studying these factors can advance our knowledge of lung cancer biology, aid in the development of better screening strategies and improve patient outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85068435081&partnerID=8YFLogxK
U2 - 10.1038/s41467-019-10879-6
DO - 10.1038/s41467-019-10879-6
M3 - Comment/debate
C2 - 31278259
AN - SCOPUS:85068435081
SN - 2041-1723
VL - 10
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 2979
ER -